Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | C1S | P09871 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12045722 | 0.94 | KMT2A (0.53) | L3MBTL1LMNAMAPK1KMT2AMAOB | |
| SCHEMBL840149 | 0.88 | PRSS1 (0.55) | KMT2APLA2G4BMAOBPRSS1 | |
| SCHEMBL851386 | 0.87 | MAPT (0.53) | L3MBTL1MAPK1PKMPARP10MAPT | |
| SCHEMBL12045718 | 0.84 | NR4A2 (0.45) | KMT2ARAB9AMAOBPRSS1 | |
| SCHEMBL31599174 | 0.83 | PARP10 (0.58) | PKMPARP10RAB9AF2F10 | |
| SCHEMBL839292 | 0.82 | RARB (0.49) | L3MBTL1MAPK1PKMPARP10MAPT | |
| SCHEMBL841269 | 0.80 | GAA (0.59) | L3MBTL1PLA2G4BMAOBPRSS1F2 | |
| SCHEMBL839231 | 0.80 | NR4A2 (0.60) | MAOBF2 | |
| SCHEMBL12045750 | 0.79 | NR4A2 (0.59) | RAB9AMAOB | |
| SCHEMBL12045711 | 0.79 | NR4A2 (0.59) | MAOBF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455590-B2 | Modified triaroylbenzene-skeleton polymer | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-04 | — | — | US | disclosed |
| US-20110319551-A1 | MODIFIED TRIAROYLBENZENE-SKELETON POLYMER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319551-A1 | MODIFIED TRIAROYLBENZENE-SKELETON POLYMER | F12, FLNB, F3 | L3MBTL1 3087/4885LMNA 2446/4885MAPK1 577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.